Theralase Technologies Inc. V.TLT

NSCLC and GBM indications

[ScienceFirst]

Tte Ral signal concerning these 2 indications will be when we'll hear about MDAB nomination with specialists in these 2 fields of expertise.

It's impossible that TLT moves ahead without such nominations.  It's a question of credibility and industry requirements.  

UHN specialists that once collaborated in these fields (Drs Yasufuku, Cypel, Zadeh, etc ...) are all possible choices as they are all aware of our technology.  UHN could then consolidate its credibility in the PDT/PDC arena.

UHN:

No one in Canada is doing more for brain health than us

[ScienceFirst]

The real signal concerning these 2 indications will be when we'll hear about MDAB nomination with specialists in these 2 fields of expertise. It's impossible that TLT moves ahead without such nominations.  It's a question of credibility and industry requirements.   UHN specialists that once collaborated in these fields (Drs Yasufuku, Cypel, Zadeh, etc ...) are all

[Infinity]

Science first, you did forget to mention that Dr. Jewett who opted to be not on the board of MSAB.  There is one other glaring omission of Dr. Kulkarni and Dr. Lilge who have been hands on with the clinical investigation.   Yes we can add new Drs on the board, however it does not bolster the company's image.

[ScienceFirst]

Infinity ... Dr. Jewett didn't leave the MSAB because he was at odd with TLT otherwise he wouldn't have commented in the press release announcing the launch of Theralase Anti-cancer.  Same apply to prof. Lilge. Boards evolve based on new directions.

[Infinity]

Hey Science first, I will grant you, you are a good spin Doctor.  There was no reason given by the management for Dr. Micheal Jewett leaving the MSAB.  Dr. Kulkarni was not on the MSAB as far as I Know. This management has been far from transparent on many issues.  We do not know why Shawn Shirazi was asked to leave.  We do not know the real reason for why Dr. Vera Madzervic

[fredgoodwinson]

Good post Infinity.

[Sunvalley]

Good morning Infinity. Interesting post .Just a little clarification if you will.Who , in your opinion is really in charge of the company? Who asked Shawn and Vera to leave.? Who set up RDW for banishment 5 years ago. ? Is there a "invisable hand " guiding the fortunes or misfortunes of TLT? Are they and have they been impeded from real progress by entities that benefit by keeping this

[StevenBirch]

Sun I think some of your questions are conspiratorial. As for management comings and goings none of that bothers me, I don't even think about it but I will allow that it's for others to think about it. But when it comes to other forces keeping this technology from coming to market I have an issue with that - if I believed that I would have sold long ago. My reasoning is that as great as

[Sunvalley]

Thank you Steven. I appreciate your point of view. 

[Legit62]

Couldnt agree more StevenBirch, i think for the most part, those that are still here in this investment are looking at a new treatment option that provides hope with less treatments, less toxicity, less cost and beneficial results. I guess what the final outcome will be will depend on the Data and nothing else, if the FDA agrees we are all set, if they dont then we wasted years in this, or they

[Eoganacht]

Great post Steven. I don't think it makes sense to talk about a "cure" for cancer. I will be more than happy if Theralase provides a safe, efficacious treatment for NMIBC, which is exactly what they are doing. From the results so far, I have little doubt that TLD1433 will receive FDA approval and even accelerated approval. The only question I have ( a point already raised by Enrique

[StevenBirch]

Eog, thanks as usual for your insight. We should have enough with the first 25 for BTD though? And it may sound crazy but they stopped Phase I early on stellar results. I know there is a big difference in going from Phase I to II and granting AA but at least the uncertainty may keep the sellers at bay and let this get some deserved momentum. 

[Eoganacht]

Hi Steven, I think we're going to get BTD in early December and maybe AA as well. Theralase has FTD and this should mean frequent communication with the FDA so they should have a pretty good idea what is about to happen. With all the insider buying and projections of commercialization in 1Q2023 things look good. Even if the FDA wants more results for AA - 2023 is still possible.

[Eoganacht]

Sorry, I meant early 2023 not early December. 

[StevenBirch]

OK, thanks Eog - so BTD yes with possibility of AA and if not now not too far off.

[Eoganacht]

We do not know why any particular advisors or employees are no longer associated with Theralase. Maybe they were asked to leave or maybe they chose to leave for reasons of their own. One thing we know for sure - the number of people Theralase has to pay salaries or stipends to has been drastically reduced in the last 2 years and this can be verified by looking at the "Our Team" from 2

[wildbird1]

Good post Eoganacht... Here is a quote that you can find in almost every " Audited Financial Statement" since May 29, 2020. This one is from April 28,2021 "Audited Financial Statement". TLT said" The decrease in administrative expenses is primarily attributed to decrease spending on general and administrative expense(40%), director and advisory fees(45%) and

[ScienceFirst]

Wildbird1... Excellent post. Managing the kitty to preserve the reach of the ultimate objective is what any good management teams try to achieve.   ______________   wildbird1 - (12/19/2022 10:38:39 AM) RE:RE:RE:RE:RE:RE:NSCLC and GBM indications  Good post Eoganacht... Here is a quote that you can find in almost every " Audited Financial Statement

[stocksnbonds458]

Infinity, as far as I know it isn't incumbent upon the management of a company to explain to you why employees leave or are fired. 

[ScienceFirst]

Infinity ... lolll Another of your bizarre posts! 1) Dr. Jewett himself clearly cited why the move of Theralase.   2) Talking of "opacity from management", first learn what management is entitled to say, when it comes to having or not having to justify layoffs, departure of staff, etc ....   3) From day one, you've been lauding Dr. Vera, while not even been